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META-RESEARCH
COVID-19 medical papers have
fewer women first authors than
expected
Abstract The COVID-19 pandemic has resulted in school closures and distancing requirements that
have disrupted both work and family life for many. Concerns exist that these disruptions caused by
the pandemic may not have influenced men and women researchers equally. Many medical journals
have published papers on the pandemic, which were generated by researchers facing the challenges
of these disruptions. Here we report the results of an analysis that compared the gender distribution
of authors on 1893 medical papers related to the pandemic with that on papers published in the same
journals in 2019, for papers with first authors and last authors from the United States. Using mixed-
effects regression models, we estimated that the proportion of COVID-19 papers with a woman first
author was 19% lower than that for papers published in the same journals in 2019, while our
comparisons for last authors and overall proportion of women authors per paper were inconclusive. A
closer examination suggested that women’s representation as first authors of COVID-19 research was
particularly low for papers published in March and April 2020. Our findings are consistent with the
idea that the research productivity of women, especially early-career women, has been affected more
than the research productivity of men.
JENS PETER ANDERSEN, MATHIAS WULLUM NIELSEN, NICOLE L SIMONE,
RESA E LEWISS AND RESHMA JAGSI*
Introduction
During the COVID-19 pandemic, many govern-
ments have shuttered schools and implemented
social distancing requirements that limit options
for childcare, while simultaneously requiring
researchers to work from home (Minello, 2020).
Robust evidence suggests that women in aca-
demic medicine shoulder more of the burden of
domestic labor within their households than do
men. One study of an elite sample of NIH-
funded physician-researchers showed that
women spent 8.5 hr more per week on parent-
ing and domestic tasks than their men peers
(Jolly et al., 2014). Recent research also sug-
gests that women in academia take on more
domestic responsibilities than men, even in dual-
career academic couples (Derrick et al., 2019).
Therefore, the recent restrictions in access to
childcare might reasonably be expected to have
disproportionate impact on women in academic
medicine, as compared to men (Viglione, 2020).
The impact of new professional service demands
that now compete with time for scholarly pro-
ductivity in academic medicine, including work
to increase the use of virtual platforms for teach-
ing and clinical care, may also disproportionately
impact women medical researchers, who are dis-
proportionately represented on clinician-educa-
tor tracks (Mayer et al., 2014).
Here, we focus on the published medical
research literature, where it may be possible to
provide an early evaluation of whether the gen-
der gap in academic productivity is widening.
The medical literature now includes a substantial
number of articles directly relating to COVID-19,
mostly generated rapidly after the broader
social restrictions came into being, in most US
states, in March 2020. We identified 15,839
articles on COVID-19 published between 1 Janu-
ary 2020 and 5 June 2020, including 1893
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articles that had a first author and/or last author
with an affiliation in the US. Here we report the
results of an analysis that compared the propor-
tion of women scientists in various author posi-
tions in this sample and a sample of 85,373
papers published in the same journals in 2019
(with first and/or last authors with a US affilia-
tion; see Materials and methods for details).
Results
In Figure 1a–c we juxtapose the observed pro-
portion of women authors (bars) for COVID-19
Figure 1. COVID-19 papers have fewer female authors than papers from 2019 published in the same journals.
(a–c) Observed (bars) and estimated (crosses and error-bars) proportions of women among authors of 1,893 US
papers on COVID-19 and 85,373 papers published in the same journals in 2019. The bars show differences in the
observed proportions of women in the first-author position (a), the last-author position (b), and any author position
(c), for papers published in 2020 COVID-19 papers (blue bars) versus papers from the same journals in 2019
(orange bars). All three panels suggest a decrease in the observed proportion of women. The crosses and error
bars show the adjusted means and 95% confidence intervals (CIs) derived from mixed regression models with
scientific journal as random effect parameter. (d–f) Adjusted means (crosses) and 95% CIs (error bars) derived from
mixed regression models for the proportion of women in the first-author position (d), last-author position (e) and
any author position (f), for papers published in 2019 (left-most crosses and error bars in each panel), papers
published in March and April 2020 (middle), and papers published in May 2020 (right). For all models, there is a
drop in March and April, followed by a partial resurgence in May. However, the uncertainty of the estimates make
these comparisons inconclusive. See Supplementary file 1 for details of the mixed regression models used to
estimate adjusted means and 95% CIs.
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papers and for papers published in the same
journals in 2019. This descriptive analysis sug-
gests that women’s respective share of first
authorships (panel a), last authorships (panel b)
and overall representation per paper (panel c) is
14%, 3% and 5% lower for COVID-19 papers
compared to 2019 papers (COVID-19 sample:
first authorships, arithmetic mean = 0.33; last
authorships, arithmetic mean: 0.28, overall pro-
portion: 0.33; 2019 sample: first authorships,
arithmetic mean = 0.38; last authorships, arith-
metic mean: 0.29; overall proportion: arithmetic
mean = 0.35).
The crosses and error-bars in Figure 1a–c
plot the adjusted means and 95% confidence
intervals derived from three mixed regression
models that adjust for variations in COVID-19
related research activities across scientific jour-
nals. The plots suggest that women’s estimated
share of first authorships, last authorships, and
overall proportion per paper is 19%, 5% and 8%
lower in the COVID-19 sample (first authorships,
adjusted mean = 0.32, CI: 0.28–0.36; last author-
ships, adjusted mean: 0.26, CI: 0.23–0.30; overall
proportion, adjusted mean = 0.36, CI: 0.33–
0.30) than in the 2019 sample (first authorships,
adjusted mean: 0.40, CI: 0.37–0.42; last author-
ships, adjusted mean: 0.28, CI: 0.26–0.31; overall
proportion, adjusted mean: 0.38, CI: 0.36–0.40)
(see Supplementary file 1 for model specifica-
tions). However, as indicated by the overlapping
confidence intervals in panels b and c, the
results are inconclusive for last authorships and
for the overall proportion of women per paper.
An earlier iteration of this study (https://arxiv.
org/abs/2005.06303v2) based on COVID-19
papers published between 1 January 2020 and 5
May 2020 suggested larger differences than
those reported here. Specifically, we found that
women’s share of first authorships, last author-
ships and general representation per author
group was 23%, 16% and 16% lower for COVID-
19 papers compared to 2019 papers published
in the same journals. The present analysis covers
a larger publication window of COVID-19
research (between 1 January 2020 and 5 June
2020), which has increased the sample from
1,179 US-based COVID-19 papers to 1893 (61%
increase). Moreover, the present analysis is
restricted to COVID-19 papers authored by US-
based first and/or last authors, while the prior
analysis included all papers with at least one US-
based author. While this difference in sampling
criteria might explain part of the observed varia-
tion in outcomes, we wanted to examine
whether there has been a change over time. In
Figure 1d–f we report the estimated proportion
of women first authors (panel d), last authors
(panel e) and overall representation per paper
(panel f), for studies published in 2019 (orange
crosshairs), during March and April 2020 (blue
crosshairs) and in May 2020 (purple crosshairs).
All three models indicate lower participation
rates for women in March and April 2020 com-
pared to May 2020, but the uncertainty of the
estimates make these results inconclusive. How-
ever, panel d shows that the relative difference
between women’s proportion of first-authored
COVID-19 papers compared to 2019 papers
increases to 23%, when the COVID-19 sample is
restricted to papers published in March and
April 2020.
To obtain a closer approximation of differen-
ces across research areas, we calculated the pro-
portion of women authorships per journal
specialty. As shown in Table 1, women are rep-
resented at lower rates across most specialty
groupings in the COVID-19 sample as compared
to the 2019 sample. The relative gap in women’s
participation is most salient in infectious dis-
eases, radiology, pathology, and public health.
Importantly, none of these groups show extreme
deviations from the overall trend. This suggests
that the observed differences are not due to a
journal-specialty bias, where specialties with a
high representation of men produce the majority
of COVID-19 research.
Discussion
Prior research has raised concerns about wom-
en’s underrepresentation among authors of
medical research, including both original
research and commentaries (Clark et al., 2017;
Hart and Perlis, 2019; Jagsi et al., 2006;
Larson et al., 2019; Silver et al., 2018). Our
study suggests that the COVID-19 pandemic
might have amplified this gender gap in the
medical literature. Specifically, we find that
women constitute a lower share of first authors
of articles on COVID-19, as compared to the
proportion of women among first authors of all
articles published in the same journals the previ-
ous year. However, our analysis also indicates
that the first-author gender gap in COVID-19
research might have decreased during the past
month of the pandemic. Our findings are consis-
tent with a contemporaneous study of pre-prints
(Vincent-Lamarre et al., 2020), which also found
women to be under-represented.
Our findings are consistent with the idea that
restricted access to child-care and increased
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work-related service demands might have taken
the greatest toll on early-career women, particu-
larly early on when the disruptions were most
unexpected, although our observational data
cannot conclusively support causal claims. As
more robust evidence becomes available, mech-
anisms which disadvantage specific ethnic, age
and gender groups should be monitored and
inform policies that promote equity
(Donald, 2020).
Some have argued that the authorship gen-
der gap in academic medicine is best explained
by a slow pipeline and the historical exclusion of
women from medical school enrollment
(Association of American Medical Colleges,
2019). However, as time has passed, and
women have reached parity in the United States
and even begun to constitute the majority of the
medical student body in many other countries,
their persistently low participation as authors has
raised concerns about bias in unblinded peer
review processes and unequal opportunities
prior to manuscript submission (Jagsi et al.,
2014; Silver, 2019). Studies have demonstrated
differences in the language used by men and
women to describe their research findings
(Lerchenmueller et al., 2019), and evidence
from the field of economics suggests that wom-
en’s writing may be held to higher standards
(Hengel, 2017). In any case, the current study
suggest that if authorship of COVID-19-related
papers is a bellwether, women’s participation in
the medical research literature may now be fac-
ing even greater challenges than before the pan-
demic (Kissler et al., 2020).
This study is limited to a relatively small sam-
ple produced early in the course of the pan-
demic and misses information on important
covariates. A key limitation is that we have not
been able to adjust for variations in COVID-19
related research activities across medical
research specialties. Since women’s representa-
tion as authors varies across specialties
(Andersen et al., 2019), this may introduce a
bias. We have attempted to mitigate this bias by
including scientific journal as random effect
parameter in the regression models, hereby
adjusting for variations in COVID-19 related
research activities across publication outlets.
Moreover, descriptive analysis that breaks down
our results by journal specialty does not suggest
that those journal specialties that might domi-
nate research related to COVID had low propor-
tions of women among authors in 2019. Indeed,
many such specialties, including infectious dis-
ease and public health, qualitatively appear to
have a markedly lower proportion of women
among authors in the 2020 COVID-related data-
set than in the 2019 dataset within those fields.
Nevertheless, future research might refine our
analysis by using Medical Subject Headings
(MeSH) to infer the research specialty of each
Table 1. Proportion of women authors on 2019 papers and COVID-19 papers by specialty.
Number of observations, N, and proportion of women by author list position for journals grouped by their specialty. The grouped col-
umns show results by journal specialty for COVID papers published in 2020 (four rightmost columns) in contrast to papers from the
same journals in 2019. Only papers with a US-based first and/or last author and clear gender for first and last author are included.
Journal specialty





First author Full group Last author First author Full group Last author
Dermatology 1811 0.44 0.42 0.37 72 0.46 0.41 0.31
Emergency medicine 1283 0.32 0.30 0.22 54 0.31 0.25 0.13
High impact general medicine 7142 0.41 0.42 0.39 194 0.31 0.37 0.35
Infectious diseases 1404 0.45 0.42 0.34 44 0.20 0.32 0.34
Internal medicine 19,980 0.36 0.33 0.25 484 0.33 0.32 0.24
Other basic sciences 6975 0.42 0.38 0.29 135 0.33 0.34 0.28
Other clinical sciences 21,869 0.40 0.37 0.31 429 0.38 0.38 0.35
Otolaryngology 1063 0.32 0.29 0.21 106 0.28 0.29 0.24
Pathology 869 0.46 0.43 0.32 66 0.27 0.37 0.30
Public health 11,015 0.47 0.41 0.35 99 0.33 0.41 0.37
Radiology 2262 0.37 0.33 0.27 60 0.25 0.28 0.17
Surgery 9700 0.21 0.20 0.13 186 0.26 0.22 0.16
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paper (Andersen et al., 2019). The US National
Library of Medicine usually assign MeSH terms
to medical papers within 3–6 months after
publication.
Although we were reliably able to determine
gender for the vast majority of the first and last
authors and a large majority of all authors, bias
is possible due to omission of those whose gen-
der could not be determined. There is no differ-
ence in the percentage of matched names
between the treatment and control groups.
Despite limitations, this early look suggests
that the previously documented gender gap in
academic medical publishing may warrant
renewed attention (Jagsi et al., 2006), and that
ongoing research on this subject is necessary as
more data become available. The need for
greater equity and diversity is most evident in
times of crisis. Abundant literature reveals the
importance of diverse teams for solving complex
problems like those related to COVID-19
(Mayer et al., 2014; Nielsen et al., 2017a;
Nielsen et al., 2018; Phillips, 2014;
Woolley et al., 2010). If societal constraints limit
the talent pool who may contribute to research
informing the crisis response, the consequences
will be profound indeed. Policies to support the
full inclusion of diverse scholars and transforma-
tion of norms for dividing labor appear to be
urgent priorities. Policies that merit consider-
ation include providing more teaching support
for female faculty or relieving them of teaching
duties, supporting child-care costs and identify-
ing child-care options, extending the tenure-
clock for the duration of the lockdown, or adjust-
ing the criteria used to assess and select candi-
dates for research funding and tenured
positions.
Materials and methods
On 5 June 2020 we searched PubMed Medline
for papers including ‘COVID-19’ or ‘SARS-CoV2’
in the title or abstract, to identify publications
most likely generated after pandemic-related
societal changes developed. This resulted in
15,843 articles, of which only four were pub-
lished prior to 2020. We extracted journal infor-
mation and matched the 2020 papers
[treatment] to 2019 papers [control] from the
same journals (N = 316,367). Only journals with
at least five papers on COVID-19 were included
in the analysis (629 of 2420 journals (25.9%),
12,855 of 15,843 papers (81.1%)). We extracted
author names for both treatment and control,
and used these to determine author gender as
in prior work (Andersen et al., 2019;
Nielsen et al., 2017b). Please see these papers
for a clarification of the gender-API algorithm
and our robustness checks of gender inference.
Gender was reliably estimated for 90.2% of
the entire sample. The majority of insecure infer-
ences are due to Chinese names, which are com-
monly not gendered (Andersen et al., 2019;
Nielsen et al., 2017b). For the papers with at
least one US author, gender could be estab-
lished for 90.7% of US first authors and 91.7% of
US last authors. Only papers with gender reliably
identified for first and last authors were
included. Limiting the sample further to papers
with at first author and/or last author with a US
address, with gender determined for authors,
gives us a treatment group of 1893 papers
(14.7%) and a control group of 85,373 papers
(30.0%). The treatment group is relatively
smaller, because proportionally more COVID-19
research has been done by researchers outside
the US, especially those in China and Italy.
As a robustness check, we selected a random
sample of 300 publications from the treatment
group and looked up information supplied by
the publishers on submission and publication
dates. Far from all publishers offer this informa-
tion and to our knowledge there are no data-
bases gathering this information consistently.
Thus, we were able to find submission dates for
153 (51.0%) of the 300 publications. Of these,
129 (84.3%) were submitted after 15 March
2020, and 276 of the 300 (92.0%) were pub-
lished after this date.
We used mixed logit models with random
intercepts and random slopes to estimate the
relationship between the dichotomous interven-
tion variable (2019 sample = 0, COVID-19 sam-
ple = 1) and (i) women’s share of first
authorships (outcome variable: man = 0,
woman = 1), (ii) women’s share of last author-
ships (outcome variable: man = 0, woman = 1),
and (iii) women’s overall representation per arti-
cle (two-vector outcome variable: number of
women, number of men; Crawley, 2012). We
included scientific journal as random effect
parameter to adjust for variations in COVID-
related research activities across scientific
journals.
For the time factor analysis, we used the date
of electronic publication (or date of publication,
if electronic publication date was not available)
from PubMed to create dichotomous variables
for COVID-19 studies published in March/April
2020 and May 2020. Following the procedure
specified above, we used mixed logit models to
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estimate the relationship between these time-
specific dichotomous variables and the three
outcome measures.
The statistical analyses were conducted in R
version 4.0.0. For the mixed logit models, we
used the ‘lme4’ v. 1.1–23 package in R. We used
the ‘emmeans’ v. 1.4.7 package to produce
adjusted means and ‘ggplot2’ v. 3.3.0 to pro-
duce figures.
To produce Table 1, we manually categorized
journals by specialty. Four authors participated
in grouping the journals, with at least two inde-
pendently coding every journal, and with dis-
crepancies addressed by team consensus.
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